Gastric perforation presenting as empyema in a patient with pancreatic cancer on bevacizumab treatment
Journal
Anticancer Research
Journal Volume
29
Journal Issue
5
Pages
1665-1667
Date Issued
2009
Abstract
Bowel perforation is a rare but life-threatening complication of bevacizumab, a new anticancer treatment. Patients with bowel perforation usually present with acute abdominal symptoms. Here a case history is presented to highlight a pancreatic cancer patient on bevacizumab chemotherapy who developed empyema as the first manifestation of gastric perforation. This unusual presentation warns physicians that bevacizumab-related bowel perforation can arise as a thoracic complication, without typical gastrointestinal manifestations, in an advanced cancer patient.
SDGs
Other Subjects
antineoplastic agent; bevacizumab; cefepime; cetuximab; adult; advanced cancer; article; cancer patient; cancer therapy; case report; clinical feature; computer assisted tomography; dyspnea; empyema; fever; human; male; pancreas abscess; pancreas cancer; priority journal; stomach perforation; thorax radiography; Antibodies, Monoclonal; Antineoplastic Agents; Empyema; Humans; Male; Middle Aged; Pancreatic Neoplasms; Tomography, X-Ray Computed
Type
journal article